Testosterone ester formulation for human use

Details for Australian Patent Application No. 2001291775 (hide)

Owner Akzo Nobel N.V.

Inventors Van Bruggen, Johann Gerhard Cornelis; Schutte, Stephanus Cornelis; Kersemaekers, Wendy Margaretha; De Nijs, Henrik

Agent Spruson & Ferguson

Pub. Number AU-B-2001291775

PCT Pub. Number WO02/15938

Priority 00202939 23.08.00 EP

Filing date 17 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 8 September 2005

International Classifications

A61K 047/44 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61P 005/26 Drugs for disorders of the endocrine system

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

8 September 2005 Application Accepted

  Published as AU-B-2001291775

12 January 2006 Standard Patent Sealed

9 November 2006 Assignment Registered

  Akzo Nobel N.V. The patent has been assigned to N.V. Organon Assignments Registered

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001291776

2001291774-DNA binding peptide domains and a method for providing domains of this type